Facilitating ethical quality improvement initiatives: Design and implementation of an initiative-specific ethics committee.


Journal

Healthcare (Amsterdam, Netherlands)
ISSN: 2213-0772
Titre abrégé: Healthc (Amst)
Pays: Netherlands
ID NLM: 101622189

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 19 08 2019
revised: 28 02 2020
accepted: 09 04 2020
entrez: 20 6 2020
pubmed: 20 6 2020
medline: 15 12 2020
Statut: ppublish

Résumé

Like all facets of healthcare practice, quality improvement (QI) should be conducted in an ethically responsible manner. For methodologically complex QI, accountability and thoughtful ethical monitoring might be particularly important. Yet, access to ethical guidance for QI, as opposed to research, is often limited. Available mechanisms tend to be ill-equipped to accommodate the rapid cycle nature of QI, and monitoring standards for QI are not well defined. Providing appropriate ethical guidance for complex, multi-site QI initiatives can be especially challenging, as the body providing guidance must be familiar with QI methods, recognize the competing interests of stakeholder groups, respond to numerous requests, and understand the initiative's design. This case report describes our solution-an initiative-specific QI Ethics Committee that provided ethical guidance and consultation to a Veterans Administration QI initiative employing local innovations and a centralized evaluation. Enhanced by multiple tables, we discuss structuring and staffing the committee, the committee's role, functions and activities, requests for ethics guidance, and our strategy applying initiative-specific ethical principles to guide recommendations. Supported by feedback obtained from stakeholder interviews, we share key insights regarding the value of: • Clarifying and marketing the committee's role to users. • Reconciling conflicting interests between site-based team members and cross-site evaluators. • Separating ethics guidance from regulatory oversight. • Addressing the ethics of evaluative design. • Adjusting the intensity of the committee's work over time. • Creating tangible products. Our approach shows promise in supporting the ethical practice of methodologically complex QI, especially in institutions that lack applicable ethics monitoring mechanisms. Building on this approach, other complex QI initiatives can develop effective and feasible methods to protect participants from unintentional ethical lapses.

Identifiants

pubmed: 32553523
pii: S2213-0764(20)30024-5
doi: 10.1016/j.hjdsi.2020.100425
pii:
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

100425

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.

Auteurs

Melissa M Bottrell (MM)

Ethics Quality Consulting, 814 Jones Street, Berkeley, CA, 94710, United States; Sigma Health Consulting LLC, 7918 Jones Branch Dr., Suite 240, McLean, VA, 22102, United States. Electronic address: melissa.bottrell@gmail.com.

Alissa Simon (A)

VA Center for the Study of Healthcare Innovation, Implementation and Policy (CSHIIP), 16111 Plummer Street, North Hills, CA, 91343, United States. Electronic address: alissa.simon@va.gov.

Cynthia Geppert (C)

National Center for Ethics in Health Care, U.S. Department of Veterans Affairs, 1501 Caballo Canyon Dr. NE, Albuquerque, NM, 87112, United States. Electronic address: ethicdoc@comcast.net.

Evelyn T Chang (ET)

VA Center for the Study of Healthcare Innovation, Implementation and Policy (CSHIIP), 16111 Plummer Street, North Hills, CA, 91343, United States; David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Ave, Los Angeles, CA, 90095, United States. Electronic address: Evelyn.Chang@va.gov.

Steven M Asch (SM)

VA Center for Innovation to Implementation (Ci2i), VA Palo Alto Health Care System, 795 Willow St, Menlo Park, 94025, United States; Stanford University School of Medicine, 291 Campus Drive, Stanford, CA, 94305, United States. Electronic address: sasch@stanford.edu.

Lisa Rubenstein (L)

Fielding School of Public Health, University of California Los Angeles, 650 Charles E Young Dr S, Los Angeles, CA, 90095, United States; Evidence-Based Practice Center, RAND Corporation, 1700 Main Street, Santa Monica, CA, 90401, United States. Electronic address: lisar@rand.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH